Survival prognoses of Heng intermediate-risk patients with metastatic renal cell carcinoma treated with immunotherapy or targeted therapy: A real-world, single-center retrospective study

PURPOSE: This study aimed to compare progression-free survival (PFS), overall survival (OS), and cancer-specific survival (CSS) in Heng intermediate-risk patients with metastatic renal cell carcinoma (mRCC) treated with first-line immunotherapy (IT) or targeted therapy (TT). MATERIALS AND METHODS: F...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Investig Clin Urol
Main Authors: Kim, Sung Han, Lee, Dong-Eun, Joung, Jae Young, Seo, Ho Kyung, Lee, Kang Hyun, Chung, Jinsoo
Formato: Artigo
Idioma:Inglês
Publicado em: The Korean Urological Association 2020
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7052413/
https://ncbi.nlm.nih.gov/pubmed/32158965
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4111/icu.2020.61.2.146
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados